|
DHDDS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.70270020305452E-10 |
| Normal-vs-Stage2 |
7.7742257076352E-12 |
| Normal-vs-Stage3 |
1.63202784619898E-12 |
| Normal-vs-Stage4 |
3.44950001895938E-09 |
| Stage1-vs-Stage2 |
2.321600E-02 |
| Stage1-vs-Stage3 |
1.965670E-02 |
| Stage1-vs-Stage4 |
6.128500E-02 |
| Stage2-vs-Stage3 |
8.669000E-01 |
| Stage2-vs-Stage4 |
9.602200E-01 |
| Stage3-vs-Stage4 |
9.205800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
6.853900E-02 |
| Normal-vs-Asian |
2.766100E-04 |
| Caucasian-vs-AfricanAmerican |
3.258200E-01 |
| Caucasian-vs-Asian |
9.903000E-01 |
| AfricanAmerican-vs-Asian |
4.208000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
4.17019999999768E-05 |
| Male-vs-Female |
2.629100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.84836607025818E-12 |
| Normal-vs-Age(41-60Yrs) |
1.55431223447522E-15 |
| Normal-vs-Age(61-80Yrs) |
9.64650581636306E-12 |
| Normal-vs-Age(81-100Yrs) |
3.413800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.050000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.645900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.008200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.150200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.479000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.799400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.475600E-02 |
| Normal-vs-Grade 2 |
2.1094237467878E-14 |
| Normal-vs-Grade 3 |
5.83469939030579E-11 |
| Normal-vs-Grade 4 |
6.08069150587198E-13 |
| Grade 1-vs-Grade 2 |
8.543300E-03 |
| Grade 1-vs-Grade 3 |
6.636500E-03 |
| Grade 1-vs-Grade 4 |
2.997400E-04 |
| Grade 2-vs-Grade 3 |
6.522200E-01 |
| Grade 2-vs-Grade 4 |
2.649700E-02 |
| Grade 3-vs-Grade 4 |
1.385370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.79479986428532E-10 |
| Normal-vs-ccB subtype |
<1E-12 |
| ccA subtype-vs-ccB subtype |
1.76100000004453E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.492380E-02 |
| N0-vs-N1 |
8.369400E-01 |
|
|
